O'Gorman Cedric

Insider profile

Performance

Overall performance
0.8

Performance over holding periods
0.8
30 days 90 days 120 days
Average return -19% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
O'Gorman Cedric's trades of Relmada Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-02-20 2024-02-20 PrS Proposed sale
40,923
74.61
US$208,381
40,923 74.61 US$208,381
2023-05-24 2023-05-23 B Purchase
96,244 +13.4%
209.83
US$2,225,147
96,244 +13.4% 209.83 US$2,225,147